Skip to content
BIO FRONTIER
Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology
EBS
Home
EBS
Biotechnology
EBS
Petri Dish Reports
Uncategorized
Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture
Feb 28, 2026
Biotechnology
EBS
Uncategorized
Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results
Feb 27, 2026
Biotechnology
EBS
Uncategorized
Emergent BioSolutions authorizes $50 million stock repurchase program
Feb 26, 2026
Search for: